Gilead Sciences commits $100 million to fight HIV/AIDS in Southern states

//Gilead Sciences commits $100 million to fight HIV/AIDS in Southern states

Gilead Sciences commits $100 million to fight HIV/AIDS in Southern states

Gilead Science of Foster City is putting $100 million toward HIV/AIDS work in Southern states. Photo: Eric Risberg, Associated Press

Photo: Eric Risberg, Associated Press

Gilead Science of Foster City is putting $100 million toward HIV/AIDS work in Southern states.

Gilead Sciences will put $100 million toward creating a program to address HIV/AIDS in the southern United States, the company announced Monday.

The Foster City biopharmaceutical giant, one of the world’s largest sellers of HIV drugs, will partner with Emory University Rollins School of Public Health, the University of Houston Graduate College of Social Work and the Southern AIDS Coalition to identify and fund local organizations that provide care and public awareness for HIV/AIDS.

Southern states account for 45 percent of all people living with an HIV diagnosis, according to the Centers for Disease Control and Prevention. Rates of new infection rival those seen in the 1980s, said Gregg Alton, Gilead’s executive vice president of corporate and medical affairs.

“In some communities, those rates are actually rising — a chilling reminder that the epidemic is far from a thing of the past,” Alton said.

By Catherine Ho

Source: http://www.sfchronicle.com/business/article/Gilead-Sciences-commits-100-million-to-fight-12403788.php